testosterone
FDA Approved, EMA Approved
Description
Testosterone replacement therapy is used in individuals with hypogonadism and disorders of sexual development. In 46,XX disorder of gonadal development with virilization, testosterone may be used for masculinizing hormone therapy when appropriate. It promotes development and maintenance of male secondary sexual characteristics.
Indications & Therapeutic Use
hypogonadism, testosterone deficiency, disorders of sexual development, gender dysphoria
Global Availability (10 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
testosterone
| Generic Name | testosterone |
| Brands | 1 brand available |
| Active Ingredient | testosterone |
| Drug Class | hypogonadism |
| Manufacturer | AbbVie |
| Dosage Forms | transdermal gel 1%, 1.62%; intramuscular injection; transdermal patch |
| Medical Code | G03BA03 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 5 days |
| Reg. Status | FDA Approved, EMA Approved |
| Clinical Trial | NCT00114920 |
| Countries | 10 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations11 Validated Nodes